🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pleural Mesothelioma

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining NCT00242723n/a1 site📍 Bethesda National Cancer Institute (NCI) Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma NCT07126509NA1 site📍 Chicago University of Chicago · Tests: Partial Pleurectomy Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma NCT07885319Phase 1, Phase 23 sites📍 Shanghai📍 Shanghai📍 Chengdu Ruijin Hospital · Tests: Ivonescimab Combined With Chemotherapy NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study NCT07121374Phase 1, Phase 21 site📍 Edegem University Hospital, Antwerp · Tests: Neoadjuvant chemo-immunotherapy, Extended pleurectomy/decortication in case of reaching operability CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites📍 Denver📍 Chicago📍 Grand Rapids Context Therapeutics Inc. · Tests: CT-95 A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413Phase 123 sites📍 Goodyear📍 Phoenix📍 Duarte IDEAYA Biosciences · Tests: IDE892, IDE397 Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma NCT05765084Phase 1, Phase 23 sites📍 Edegem📍 Ghent📍 Sint-Niklaas University Hospital, Antwerp · Tests: Dendritic cell vaccination, Atezolizumab, Platinum/pemetrexed based chemotherapy Olaparib in Patients With HRD Malignant Mesothelioma NCT04515836Phase 21 site📍 Chicago University of Chicago · Tests: Olaparib SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma NCT05568680Phase 15 sites📍 Tampa📍 Westwood📍 Philadelphia Verismo Therapeutics · Tests: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors NCT07443020Phase 11 site📍 Pittsburgh Allegheny Singer Research Institute (also known as Alleghen… · Tests: locally manufactured adoptive cellular therapy (ACT) product, Interleukin-2 (IL-2) Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS NCT06886672n/a2 sites📍 Pavia📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso) NCT04996017Phase 319 sites📍 Meldola📍 Alessandria📍 Bari Gruppo Oncologico Italiano di Ricerca Clinica · Tests: Atezolizumab 1200 mg in 20 ML Injection, Placebo TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO NCT05628376n/a1 site📍 London University College, London A Study of MT027 in Patients with Pleural Malignant Tumors NCT06726564Phase 11 site📍 Beijing Suzhou Maximum Bio-tech Co., Ltd. · Tests: MT027 cells suspension A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas NCT04104776Phase 1, Phase 280 sites📍 Tampa📍 Atlanta📍 Chicago Novartis Pharmaceuticals · Tests: Tulmimetostat, Enzalutamide TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors NCT07713732Phase 13 sites📍 Camperdown📍 Malvern📍 Nedlands Treeline Biosciences, Inc. · Tests: TLN-499, Venetoclax Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO) NCT06637345n/a1 site📍 Aviano Centro di Riferimento Oncologico - Aviano A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma NCT06057935Phase 213 sites📍 Chicago📍 Ann Arbor📍 St Louis Memorial Sloan Kettering Cancer Center · Tests: Pemetrexed, Cisplatin, Carboplatin SW-682 in Advanced Solid Tumors NCT06251310Phase 18 sites📍 Scottsdale📍 Los Angeles📍 Sacramento SpringWorks Therapeutics, Inc., a healthcare company of Mer… · Tests: SW-682, Combination Therapy Evaluation of Skin Tests in Biotherapy Allergies NCT06971848NA1 site📍 Angers University Hospital, Angers · Tests: Drug skin tests (investigating hypersensitivity to a biotherapy) TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma NCT04969315Phase 1, Phase 22 sites📍 Los Angeles📍 Houston Portage Biotech · Tests: TT-10, TT-4 Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma NCT06037941NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: E-Nose testing, Research blood Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma NCT05655078NA25 sites📍 Eastbourne📍 Saint Leonards-on-Sea📍 Reading University College, London · Tests: Proton beam therapy Multidimensional Omics Analysis in Malignant Pleural Mesothelioma NCT07561190n/a4 sites📍 Catania📍 Naples📍 Reggio Emilia Azienda USL Reggio Emilia - IRCCS A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites📍 Duarte📍 Los Angeles📍 San Francisco Nurix Therapeutics, Inc. · Tests: NX-1607, Paclitaxel Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing NCT04981119n/a16 sites📍 Gilbert📍 Phoenix📍 Duarte A2 Biotherapeutics Inc. · Tests: Apheresis, Next Generation Sequencing (NGS), Long Range NGS HLA typing Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors NCT06566079Phase 1, Phase 210 sites📍 Denver📍 Chicago📍 Cleveland InSilico Medicine Hong Kong Limited · Tests: ISM6331 TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study NCT05538806n/a23 sites📍 Gauting📍 Regensburg📍 Harburg NovoCure Ltd. · Tests: TTFields Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma NCT05647265Phase 2132 sites📍 Anchorage📍 Anchorage📍 Anchorage Alliance for Clinical Trials in Oncology · Tests: Nivolumab, Ipilimumab, Surgical Procedure, Computed Tomography, Magnetic Resonance Imaging dENdritic Cell Therapy Combined With SURgEry in Mesothelioma NCT05304208Phase 11 site📍 Rotterdam Erasmus Medical Center · Tests: Mesopher
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy